Altimmune (ALT) Other Non-Current Assets (2010 - 2026)

Altimmune (ALT) has 17 years of Other Non-Current Assets data on file, last reported at $746000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 53.87% year-over-year to $746000.0 in Q1 2026; TTM through Mar 2026 was $746000.0, a 53.87% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 13.06% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $746000.0, down from $1.4 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for ALT reached as high as $1.7 million in Q2 2024 and fell as low as $299000.0 in Q1 2024.
• Historically, Other Non-Current Assets has averaged $987823.5 across 5 years, with a median of $747000.0 in 2022.
• Across the five-year window, Other Non-Current Assets soared 603.38% in 2022 and sank 53.87% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $615000.0 in 2022, then slumped by 40.98% to $363000.0 in 2023, then soared by 351.52% to $1.6 million in 2024, then declined by 13.06% to $1.4 million in 2025, then tumbled by 47.65% to $746000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $746000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.